Vesicare (solifenacin succinate) for Bladder Dysfunction in MS

When people with multiple sclerosis (MS) experience bladder dysfunction such as urinary frequency and incontinence, doctors may prescribe a medication such as Vesicare (solifenacin succinate).

Vesicare is a medicine for treating overactive bladder with symptoms of urgency, frequency, and leakage. It is an antimuscarinic drug, which reduces involuntary contractions of the bladder muscles and increases bladder capacity. Vesicare exerts competitive antagonistic effects at the muscarinic receptors, binding to the receptors that help the bladder muscle to contract.

Vesicare’s dosage is initially 5 mg taken orally once daily; the dose may increase to 10 mg a day if the 5 mg dose is well tolerated.

The therapy may cause blurred vision, so use caution while driving or doing unsafe tasks. Common side effects are dry mouth, constipation, and indigestion.

At this point, there are no Vesicare generics available due to patent expiration dates, although one has already been FDA-approved.

Read the latest news here about bladder dysfunction and multiple sclerosis.

Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Dancing Doodle

Did you know some of the news and columns on Multiple Sclerosis News Today are recorded and available for listening on SoundCloud? These audio news stories give our readers an alternative option for accessing information important for them.

Listen Here